Veramed

Veramed is a pioneering Clinical Research Organization (CRO) that has redefined intelligent healthcare decision-making through end-to-end biometrics services. Founded in 2012 by Matt and Emma Jones, the company has grown from a vision to create a high-quality, collaborative, people-focused CRO into a globally recognized partner trusted by pharmaceutical and biotechnology companies worldwide.

Headquartered in Twickenham, England, with offices across the UK, Europe, US, and India, Veramed delivers expert data management, biostatistics, and programming services for Phase I-IV clinical trials. The company's global team of over 650 data managers, statisticians, and statistical programmers supports analysis and consultancy across a variety of therapeutic areas, including oncology, respiratory, and rare disease. Veramed operates under a functional service provider (FSP) model alongside project-based solutions, providing flexible engagement options tailored to client needs.

What sets Veramed apart is its unwavering commitment to quality, integrity, and humanity. The company has earned B Corp Certification, demonstrating its dedication to social and environmental responsibility. Veramed combines precision engineering with advanced automation and AI-powered solutions to ensure industry-leading delivery. Its reputation is built not on promises but on rock-solid biometrics, systems that scale, and technologies that eliminate surprises for clients. With an estimated annual revenue of $250-500M, Veramed continues to set the new standard for biometrics in clinical trials.